Combined employer premium contributions and deductibles exceeded 10% of median household income in 19 states, ...

Community-academic collaboration can reduce access burdens and strengthen continuity of care, says Anasuya Gunturi, MD, PhD.

Training at West Point reinforced the importance of mentorship and the humanistic dimensions of medical practice.

This episode examines the barriers to accessing HER2-targeted therapies for non-small cell lung cancer (NSCLC) and strategies ...

CORALreef Lipids randomized 2,909 adults (2:1) to enlicitide 20 mg daily or placebo across 168 sites, using stratification by renal function, baseline statin use, and region. LDL-C at week 24 ...

Our findings indicate that a large commercial insurer is increasingly covering acupuncture for its beneficiaries. Unlike Medicare Part B, which limits acupuncture coverage to chronic low back pain, ...

Susan Vadaparampil, PhD, MPH, of Moffitt Cancer Center, concludes her conversation with The American Journal of Managed Care® at last month’s Institute for Value-Based Medicine ® event in Tampa, ...

PBM reforms, Medicare Advantage trends, TrumpRx launch, and Express Scripts settlement highlight key shifts in drug pricing, ...

Multiple myeloma was once viewed as an incurable diagnosis, but Ameet Patel, MD, of Florida Cancer Specialists & Research ...

The Consolidated Appropriations Act of 2026 gives CMS more leverage to intercept when pharmacy benefit managers are driving up prices in Medicare Part D, explains Jesse Dresser, Esq.

Low-sodium oxybate (Xywav) reduces excessive sleep and daytime naps in idiopathic hypersomnia, with placebo withdrawal worsening sleep duration and symptoms.

Melissa L. Johnson, MD, is now chief scientific officer while retaining leadership of lung cancer research, and Erika P. Hamilton, MD, is now chief development officer, late phase, while remaining the ...